- Report
- March 2024
- 677 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- November 2024
- 270 Pages
Global
From €2338EUR$2,450USD£1,959GBP
- Report
- March 2025
- 197 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 184 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 183 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 185 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 197 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 186 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 188 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2024
- 125 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- August 2024
- 146 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 135 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- January 2025
- 139 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- March 2025
- 182 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 88 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 171 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- March 2025
- 194 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 179 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 174 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 158 Pages
Global
From €4724EUR$4,950USD£3,958GBP

The Immunosorbent Assay (ELISA) market is a segment of the Diagnostics industry that focuses on the detection and quantification of antigens and antibodies in biological samples. ELISA is a laboratory technique used to detect and measure the presence of specific proteins, hormones, and other molecules in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of drugs and toxins in the body.
The ELISA market is driven by the increasing prevalence of chronic diseases, the growing demand for point-of-care testing, and the increasing demand for personalized medicine. The market is also driven by technological advancements in the field of diagnostics, such as the development of automated ELISA systems.
Some of the major companies in the ELISA market include Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Roche Diagnostics. Show Less Read more